We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ingevity (NGVT) Earnings Meet, Sales Beat Estimates in Q2
Read MoreHide Full Article
Ingevity Corporation (NGVT - Free Report) reported profits of $20.2 million or 49 cents per share in second-quarter 2020, down 64.4% from $56.8 million or $1.34 per share a year ago.
Adjusted earnings per share for the reported quarter were 63 cents, in line with the Zacks Consensus Estimate.
The company’s revenues fell 23.3% year over year to $270.6 million in the quarter on account of weaker demand, especially in the automotive industry, fuelled by the economic impacts of the coronavirus pandemic. However, the top line surpassed the Zacks Consensus Estimate of $251.1 million.
Adjusted EBITDA declined 38% year over year to $67.2 million in the quarter.
Ingevity Corporation Price, Consensus and EPS Surprise
Revenues from the Performance Chemicals division declined 18.9% year over year to $186.2 million in the quarter under review. Softened demand in Industrial Specialties and Oilfield Technologies was offset by relatively reasonable strength in Pavement Technologies and Engineered Polymers.
Revenues from the Performance Materials unit decreased 31.4% to $84.4 million. The sales decline in North America was partly offset by the rebounding automotive business in China.
Balance Sheet
Ingevity ended the quarter with cash and cash equivalents of $177.6 million, up 233.2% year over year. Long-term debt was $1,308.5 million, down 4% year over year.
Outlook
The company reaffirmed its sales guidance for 2020 of between $1.1 billion and $1.2 billion. It also anticipates adjusted EBITDA of $310-$350 million for the year.
Price Performance
Shares of Ingevity have lost 40.3% in the past year against the industry’s growth of 27.5%.
Zacks Rank & Stocks to Consider
The company currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the basic materials space are Royal Gold, Inc. (RGLD - Free Report) , Equinox Gold Corp. (EQX - Free Report) and B2Gold Corp (BTG - Free Report) .
Royal Goldhas a projected earnings growth rate of 62.1% for the current year. The company’s shares have gained 17.2% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Equinox Gold has a projected earnings growth rate of 255.2% for the current year. The stock has gained around 101% in a year. It currently has a Zacks Rank of 2 (Buy).
B2Gold has an expected earnings growth rate of 257.1% for 2020. The company’s shares have rallied 104.2% in the past year.It is presently a Zacks #2 Ranked player.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Image: Bigstock
Ingevity (NGVT) Earnings Meet, Sales Beat Estimates in Q2
Ingevity Corporation (NGVT - Free Report) reported profits of $20.2 million or 49 cents per share in second-quarter 2020, down 64.4% from $56.8 million or $1.34 per share a year ago.
Adjusted earnings per share for the reported quarter were 63 cents, in line with the Zacks Consensus Estimate.
The company’s revenues fell 23.3% year over year to $270.6 million in the quarter on account of weaker demand, especially in the automotive industry, fuelled by the economic impacts of the coronavirus pandemic. However, the top line surpassed the Zacks Consensus Estimate of $251.1 million.
Adjusted EBITDA declined 38% year over year to $67.2 million in the quarter.
Ingevity Corporation Price, Consensus and EPS Surprise
Ingevity Corporation price-consensus-eps-surprise-chart | Ingevity Corporation Quote
Segment Review
Revenues from the Performance Chemicals division declined 18.9% year over year to $186.2 million in the quarter under review. Softened demand in Industrial Specialties and Oilfield Technologies was offset by relatively reasonable strength in Pavement Technologies and Engineered Polymers.
Revenues from the Performance Materials unit decreased 31.4% to $84.4 million. The sales decline in North America was partly offset by the rebounding automotive business in China.
Balance Sheet
Ingevity ended the quarter with cash and cash equivalents of $177.6 million, up 233.2% year over year. Long-term debt was $1,308.5 million, down 4% year over year.
Outlook
The company reaffirmed its sales guidance for 2020 of between $1.1 billion and $1.2 billion. It also anticipates adjusted EBITDA of $310-$350 million for the year.
Price Performance
Shares of Ingevity have lost 40.3% in the past year against the industry’s growth of 27.5%.
Zacks Rank & Stocks to Consider
The company currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the basic materials space are Royal Gold, Inc. (RGLD - Free Report) , Equinox Gold Corp. (EQX - Free Report) and B2Gold Corp (BTG - Free Report) .
Royal Goldhas a projected earnings growth rate of 62.1% for the current year. The company’s shares have gained 17.2% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Equinox Gold has a projected earnings growth rate of 255.2% for the current year. The stock has gained around 101% in a year. It currently has a Zacks Rank of 2 (Buy).
B2Gold has an expected earnings growth rate of 257.1% for 2020. The company’s shares have rallied 104.2% in the past year.It is presently a Zacks #2 Ranked player.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>